Evidence mapPaperPMID 39331645Full record

ArticlePloS one2024

Development of explicit definitions of potentially inappropriate prescriptions for antidiabetic drugs in patients with type 2 diabetes: A multidisciplinary qualitative study.

Erwin Gerard, Paul Quindroit, Matthieu Calafiore, Jan Baran, Sophie Gautier, Stéphanie Genay, Bertrand Decaudin, Madleen Lemaitre, Anne Vambergue, Jean-Baptiste Beuscart

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Erwin GerardCHU Lille, ULR 2694 - METRICS: Evaluation des Technologies de Santé et des Pratiques Médicales, Univ. Lille, Lille, France.ORCID https://orcid.org/0000-0002-7712-4138
Paul QuindroitCHU Lille, ULR 2694 - METRICS: Evaluation des Technologies de Santé et des Pratiques Médicales, Univ. Lille, Lille, France.
Matthieu CalafioreCHU Lille, ULR 2694 - METRICS: Evaluation des Technologies de Santé et des Pratiques Médicales, Univ. Lille, Lille, France.ORCID https://orcid.org/0000-0002-4755-5172
Jan BaranDepartment of General Practice, University of Lille, Lille, Lille, France.
Sophie GautierCHU de Lille, UMR-S1172, Center for Pharmacovigilance, Univ. Lille, Lille, France.
Stéphanie GenayCHU Lille, Institut de Pharmacie, Lille, France.
Bertrand DecaudinCHU Lille, Institut de Pharmacie, Lille, France.
Madleen LemaitreCHU Lille, ULR 2694 - METRICS: Evaluation des Technologies de Santé et des Pratiques Médicales, Univ. Lille, Lille, France.
Anne VambergueDepartment of Diabetology, CHU Lille, Endocrinology, Metabolism and Nutrition, Lille University Hospital, Lille, France.
Jean-Baptiste BeuscartCHU Lille, ULR 2694 - METRICS: Evaluation des Technologies de Santé et des Pratiques Médicales, Univ. Lille, Lille, France.ORCID https://orcid.org/0000-0002-0734-8371

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe management of type 2 diabetes mellitus patients has changed over the past decade, and a large number of antidiabetic drug treatment options are now available. This complexity poses challenges for healthcare professionals and may result in potentially inappropriate prescriptions of antidiabetic drugs in patients with type 2 diabetes mellitus which can be limited using screening tools. The effectiveness of explicit tools such as lists of potentially inappropriate prescriptions has been widely demonstrated. The aim was to set up nominal groups of healthcare professionals from several disciplines and develop a list of explicit definition of potentially inappropriate prescriptions of antidiabetic drugs.

methodsIn a qualitative, nominal-groups approach, 30 diabetologists, general practitioners, and pharmacists in France developed explicit definitions of potentially inappropriate prescriptions of antidiabetic drugs in patients with type 2 diabetes mellitus. A nominal group technique is a structured method that encourages all the participants to contribute and makes it easier to reach an agreement quickly. Each meeting lasted for two hours.

resultsThe three nominal groups comprised 14 pharmacists, 10 diabetologists, and 6 general practitioners and generated 89 explicit definitions. These definitions were subsequently merged and validated by the steering committee and nominal group participants, resulting in 38 validated explicit definitions of potentially inappropriate prescriptions of antidiabetic drugs. The definitions encompassed four contexts: (i) the temporary discontinuation of a medication during acute illness (n = 9; 24%), (ii) dose level adjustments (n = 23; 60%), (iii) inappropriate treatment initiation (n = 3; 8%), and (iv) the need for further monitoring in the management of type 2 diabetes mellitus (n = 3; 8%).

conclusionThe results of our qualitative study show that it is possible to develop a specific list of explicit definitions of potentially inappropriate prescriptions of antidiabetic drugs in patients with type 2 diabetes mellitus by gathering the opinions of healthcare professionals caring for these patients. This list of 38 explicit definitions necessitates additional confirmation by expert consensus before use in clinical practice.

Indexed as

Diabetes Mellitus, Type 2Hypoglycemic AgentsInappropriate PrescribingFemaleFranceGeneral PractitionersHumansMaleMiddle AgedPharmacistsQualitative ResearchHypoglycemic Agents

Identifiers

PMID39331645
PMCPMC11432865

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.